P. Richard Harrigan

机构：Intellicell Biosciences (United States) · ORCID：0000-0003-2631-3390

发表论文 313 篇 · 总被引 17134 次 · h-index 67

代表论文

• Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping (2020 · Viruses · 被引 51)
• Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals (2022 · JHEP Reports · 被引 44)
• Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015 (2020 · The Journal of Infectious Diseases · 被引 36)
• Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium (2020 · Viruses · 被引 30)
• Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV (2022 · HIV Medicine · 被引 28)
• Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir (2022 · Antiviral Research · 被引 24)